Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Solicitation opportunity from New York was posted on March 31, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Botulism Immune Globulin Intravenous (BabyBIG)

Closed
2120634State & Local

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325411
New
Federal
Reagent Generation for Bioanalytical Method Development on Biologics Therapeutics
Solicitation # 75N98027R00020
The National Center for Advancing Translational Sciences within the National Institutes of Health has issued a Sources Sought notice for an IDIQ contract focused on reagent generation for bioanalytical method development on biologics therapeutics. The primary objective is to identify qualified sources capable of generating and delivering high-affinity, specific anti-drug antibodies, including neutralizing antibodies and antibodies against carriers or gene-of-interest protein products. These reagents will support the quantification of novel biologic drugs in biological matrices such as plasma, serum, and tissue homogenates. The anticipated scope includes the production of polyclonal and monoclonal antibodies, specificity characterization, and the delivery of purified antibodies at an estimated scale of 10 to 50 mg per reagent. The required performance standards are rigorous, demanding adherence to US FDA current Good Manufacturing Practice, Good Laboratory Practice, and Good Clinical Practice, as well as ICH and ISO regulations. Contractors must maintain a comprehensive Quality Management Plan and an independent Quality Assurance Unit to ensure all products meet strict quality requirements. Additional requirements include the development of standard operating procedures for packaging and shipping, the maintenance of secure facilities with restricted access, and the implementation of contingency plans for catastrophic events. The anticipated period of performance for this effort is ten years. Interested respondents must be registered in the System for Award Management and provide a capability statement under NAICS code 325411 by November 30, 2026.
National Institutes Of Health Nida

POSTED

1 day ago

DEADLINE

in 13 days
NAICS: 325411
New
DIBBS
ANALGESIC GEL, TOPICAL
Solicitation # SPE2DP-27-T-0371
Solicitation SPE2DP-27-T-0371 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Biofreeze topical analgesic gel. The requirement consists of four units of colorless gel containing 5% Menthol USP in 4 oz (118ml) tubes, intended for use by adults and children aged two years and older. The product is classified as a Type I (Code M) item with a non-extendable shelf life of 24 months and must be stored in a cool, dry place between 20-25 C (68-77 F) away from direct sunlight. Due to its flammable nature, the gel must be kept away from excessive heat or open flames. Delivery is specified as FOB Destination to the 0024 QM Co Composite Suppl at Joint Base Lewis MCCH, WA, with a required delivery date of November 16, 2026, and a delivery window of 20 days. Packaging must follow MIL-STD-2073-1E and RP001 DLA packaging requirements, utilizing suitable sealed unit containers and commercial exterior shipping containers. Marking must strictly adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. The contract incorporates various FAR and DFARS clauses, including requirements for equal opportunity for workers with disabilities, safeguarding covered defense information, and compliance with the Buy American Act and Berry Amendment. Invoicing and payment must be processed electronically through the Wide Area WorkFlow (WAWF) system.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 6 days
NAICS: 325411
New
DIBBS
KETOROLAC TROMETHAMINE
Solicitation # SPE2DP-27-T-0291
This procurement, solicitation SPE2DP-27-T-0291, is a small business set-aside issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the acquisition of Ketorolac Tromethamine Injection. The requirement is for 10 packages of USP 15 mg per ml solution provided in pre-filled syringes, identified by NSN 6505-01-666-2156. The product is classified as a Type I (Code M) item with a non-extendable shelf life of 24 months. Delivery is required FOB Destination to the 1AD Sustainment Brigade SSA at Fort Bliss, Texas, with a required delivery date of November 13, 2026, and a delivery timeline of 20 days. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical marking, although MIL-STD-129 remains applicable for general shipment and storage. Packaging must be commercial and include suitable sealed unit containers, with specific requirements for hazardous materials under FED-STD-313 and TQ requirement IP025. Suppliers must submit Safety Data Sheets and Hazard Communication Standard labels for review prior to award. Inspection and acceptance will occur at the destination. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various FAR and DFARS clauses regarding cybersecurity, domestic preferences, and small business representations.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

5 days ago

DEADLINE

in 1 day

AI Contract Overview

Show more

SUNY Upstate Medical University is seeking proposals to purchase Botulism Immune Globulin Intravenous (BabyBIG) from the State of California Department of Health under its discretionary authority, allowing procurement without a formal competitive bidding process. Interested vendors must contact the designated hospital representative, Michael Cushner, within 15 business days of the advertisement to submit their proposals, adhering to strict communication protocols outlined by NYS law, including the NYS Lobbying Law. The contract is set for a one-year period from March 28, 2025, to March 27, 2026, with a procurement value estimated between $500,000 and $1,500,000, and is located in Onondaga County, New York. Vendors must also provide current NYS Workman’s Compensation and Disability Forms, complete vendor responsibility documentation, and comply with relevant state tax and procurement laws. This procurement is not set aside for Service-Disabled Veteran-Owned businesses, and there have been no recent similar contracts awarded to the same entities within the past five years. The solicitation emphasizes the importance of only contacting the designated individual, Michael Cushner, for inquiries related to this procurement.

General Info

Documents

0

No documents available

No documents were posted with this contract.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

This one is closed. Find the next one like it.

Open contracts like this one, right now:

  • ISOPROPYL ALCOHOLOpen now, due in 7 days
  • INFLUENZA VIRUS VACCINOpen now, due in 3 days
See open contracts like this

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyState University of New York (SUNY)
Contacts1 person available
OfficeN/A

Full Description

Show more
SUNY Upstate Medical University (SUNY Upstate) intends to purchase Botulism Immune Globulin Intravenous (BabyBIG) provided by the State of California Department of Health under its discretionary authority, pursuant to NYS Education Law §355(5)(a), the below described commodity/product or service which authorizes purchases without a formal competitive process in certain circumstances.  A sealed bid will not be held.  If you are interested in providing a proposal for the below described commodity/product or service, you must contact the appropriately designated Hospital contact in this advertisement within 15 business days of this Advertisement Notice.  Contacting any other individuals at SUNY Upstate in connection with this advertisement may constitute a violation of New York State Finance Law. This procurement is subject to NYS Finance Law §139 j&k, AKA the Lobbying Law.  Therefore, vendors are cautioned that the only permissible contact for this procurement is the individual listed below.  Failure to comply with this requirement can range from no contract award to debarment from sales to any NYS Agency. Successful contractor shall be required to submit valid and current NYS Workman’s Compensation and Disability Forms. Successful contractor shall be required to complete and submit applicable documents related to Vendor Responsibility, NYS Finance Law §139 j&k, and New York State’s Tax Law Section 5-a. Commodity/Product or Service Description: Botulism Immune Globulin Intravenous (BabyBIG) Anyone who can provide the above described product(s) is invited to contact Michael Cushner at Sign up to see this detail Service-Disabled Veteran-Owned Set Aside: No Due date:04/21/2025 Contract term: 3/28/25-3/27/25 County(ies): Onondaga Business entities awarded an identical or substantially similar procurement contract within the past five years: N/A

More opportunities from State University of New York (SUNY)

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS